Compare Kabelindo Murni Tbk (KBLM) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kabelindo Murni Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Kabelindo Murni Tbk trades at Rp306 (market cap 340.48B, 11.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 11.1K). Which is the better fit depends on your goals.
| KBLM | LABS | |
|---|---|---|
Market Cap | 340.48B | 635.95B |
Volume | 11.1K | 843K |
Lot | 111 | 8.43K |
Turnover | 3.37M | 137.6M |
Average Price | 303.35 | 163.22 |
Value | 3.37M | 137.6M |
Indicative Equilibrium Price | 306 | 165 |
Indicative Equilibrium Volume | 1 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kabelindo Murni Tbk
PT Kabelindo Murni Tbk (the Company) was established based on Notarial Deed No. 71 dated October 11, 1979 of Fredrik Alexander Tumbuan, S.H. PT Kabelindo Murni Tbk manufactures cable and cable fittings using raw materials such as polyethylene and heat shrinkable materials tubes. Installed production capacity has reached 26,000 tons of power cables and 1,330,000 Km pair of telephone cables.
Read more on KBLM →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
